» Articles » PMID: 34800918

The Role of Feature-based Radiomics for Predicting Response and Radiation Injury After Stereotactic Radiation Therapy for Brain Metastases: A Critical Review by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (yAIRO)

Overview
Journal Transl Oncol
Specialty Oncology
Date 2021 Nov 20
PMID 34800918
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: differential diagnosis of tumor recurrence and radiation injury after stereotactic radiotherapy (SRT) is challenging. The advances in imaging techniques and feature-based radiomics could aid to discriminate radionecrosis from progression.

Methods: we performed a systematic review of current literature, key references were obtained from a PubMed query. Data extraction was performed by 3 researchers and disagreements were resolved with a discussion among the authors.

Results: we identified 15 retrospective series, one prospective trial, one critical review and one editorial paper. Radiomics involves a wide range of imaging features referred to necrotic regions, rate of contrast-enhancing area or the measure of edema surrounding the metastases. Features were mainly defined through a multistep extraction/reduction/selection process and a final validation and comparison.

Conclusions: feature-based radiomics has an optimal potential to accurately predict response and radionecrosis after SRT of BM and facilitate differential diagnosis. Further validation studies are eagerly awaited to confirm radiomics reliability.

Citing Articles

Efficacy and Low Toxicity of Normo-Fractionated Re-Irradiation with Combined Chemotherapy for Recurrent Glioblastoma-An Analysis of Treatment Response and Failure.

Pepper N, Prange N, Troschel F, Kroger K, Oertel M, Kuhlmann T Cancers (Basel). 2024; 16(21).

PMID: 39518091 PMC: 11545019. DOI: 10.3390/cancers16213652.


Fractionated Stereotactic Intensity-Modulated Radiotherapy for Large Brain Metastases: Comprehensive Analyses of Dose-Volume Predictors of Radiation-Induced Brain Necrosis.

Murai T, Kasai Y, Eguchi Y, Takano S, Kita N, Torii A Cancers (Basel). 2024; 16(19).

PMID: 39409947 PMC: 11482639. DOI: 10.3390/cancers16193327.


Adoption of Hybrid MRI-Linac Systems for the Treatment of Brain Tumors: A Systematic Review of the Current Literature Regarding Clinical and Technical Features.

Guerini A, Nici S, Magrini S, Riga S, Toraci C, Pegurri L Technol Cancer Res Treat. 2023; 22:15330338231199286.

PMID: 37774771 PMC: 10542234. DOI: 10.1177/15330338231199286.


AI Evaluation of Imaging Factors in the Evolution of Stage-Treated Metastases Using Gamma Knife.

Buzea C, Buga R, Paun M, Albu M, Iancu D, Dobrovat B Diagnostics (Basel). 2023; 13(17).

PMID: 37685391 PMC: 10486549. DOI: 10.3390/diagnostics13172853.


Development and validation of a radiomics-based prediction pipeline for the response to stereotactic radiosurgery therapy in brain metastases.

Du P, Liu X, Xiang R, Lv K, Chen H, Liu W Eur Radiol. 2023; 33(12):8925-8935.

PMID: 37505244 DOI: 10.1007/s00330-023-09930-4.